Board of Advisors

Scientific Advisors

In addition to its management team and Board, NewCardio has assembled a world class Scientific Advisory Board of recognized experts in the area of cardiology and the sub-specialty of electrophysiology.

Mark Josephson, MD, SAB Chairman

Chief of Cardiology, Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School. Professor of Medicine at Harvard Medical School. Previously Director of the Harvard Thorndike Electrophysiology Institute. He is an internationally renowned international expert in cardiac electrophysiology. Dr. Josephson is a world expert on the pathophysiology of ventricular tachycardia and has authored the definitive text of cardiac electrophysiology. In 2001, Dr. Josephson was awarded the NASPE Pioneer Award and the NASPE Fellowship Training Award.

Peter R. Kowey, MD., Advisor

Dr. Kowey is an industry leading cardiologist and a Fellow of several professional organizations and his principal area of interest is cardiac rhythm disturbances. He is currently President of the Heart Center of the Lankenau Hospital Main Line Health System and also Professor of Medicine and Clinical Pharmacology at Jefferson Medical College. He has been the recipient of over 150 grants and has authored or co-authored more than 400 papers and scientific reports. Dr. Kowey is a Fellow of several professional organizations including the Clinical Council of the American Heart Association, the American College of Cardiology, the American College of Physicians, the College of Physicians of Philadelphia, the American College of Chest Physicians, and the American College of Clinical Pharmacology. He spent nine years as a member of the Cardiorenal Drug Advisory Committee, four years on the Cardiovascular Devices Committee of the U.S. Food and Drug Administration, and is on the Expert Advisory Panel of the U.S. Pharmacopeial convention. In addition, he serves as an ad-hoc consultant to 94 organizations, including many of the largest pharmaceutical companies in the world, such as Pfizer, Merck, GlaxoSmithKline, Amgen, Eli Lilly and Company, and Bristol-Myers Squibb. He has also chaired several data and safety monitoring boards for clinical trials. He is the co-editor of three textbooks regarding cardiac arrhythmia and serves as a referee for manuscript review for 25 journals, as well as sitting on the editorial boards of the Heart Rhythm Journal and the Journal of Cardiovascular Electrophysiology.

Craig M. Pratt, M.D., Advisor

Currently Professor of Medicine at Weill Cornell Medical College, Director of Research for the Methodist DeBakey Heart Center and Director of the Coronary Intensive Care Unit at The Methodist Hospital in Houston, Texas. He has served as a member of the Cardiovascular and Renal Drugs Advisory Board of the Food and Drug Administration (FDA) for 11 years, including Chairman of the Cardio-Renal Advisory Board from 1987-1993; continues to serve as a consultant to the FDA's Center for Drug Evaluation and Research. Dr. Pratt has also been the principal investigator for numerous trials of drug and device investigations for the treatment of arrhythmias, heart failure, ischemia and other cardiovascular disorders.

Dorin Panescu, Ph.D.

Dr. Panescu joined NewCardio from St. Jude Medical, Inc. (NYSE: STJ) where he most recently served as Director, Technology Development, for the Company's Cardiac Rhythm Management Division. In this role, he managed broad functional teams tasked with the development of heart failure trending and wireless remote monitoring features for implantable cardiac defibrillators and pacemakers. Before St. Jude Medical, Inc., Dr. Panescu served as Vice President of Research and Development, Operations and Intellectual Property for Refractec, Inc., where he directed R&D and Operations for the development of keratoplasty RF ablation equipment and set the company's IP strategy. Refractec, Inc. was the first company to get PMA approval from the FDA for the surgical treatment of presbyopia. Previously, he served as Sr. Director of Systems Development for Boston Scientific Corporation (NYSE: BSX), directing new product development for the Electrophysiology Division. Boston Scientific, Electrophysiology, is the world market leader in RF cardiac ablation systems. Dr. Panescu is credited with 130 issued U.S. patents and 70 published or pending U.S. patent applications covering a wide spectrum of technologies for medical devices, specifically related to devices and methods for medical imaging, diagnosis and therapies, as well as cardiac mapping and ablation. Dorin holds Ph.D. and M.S. degrees in Electrical and Computer Engineering from the University of Wisconsin at Madison.

Technology Advisors

The role of the Technology advisory Committee (TAC) is to participate in setting technology development directions and provide expert opinion and help with the current technical issue.

Gari Clifford, Ph.D.

Currently is a Principal Research Scientist at the Harvard-MIT Division of Health Sciences, where he is the engineering manager of a National Institute of Health (NIH)-funded research program "Integrating Data, Models, and Reasoning in Critical Care," and a major contributor to the well-known Physionet Research Resource. He has worked in industry on the design and production of several FDA-approved medical devices. Dr. Clifford has taught at Oxford, MIT, and Harvard, and is currently an instructor of Biomedical Engineering at MIT. He is on the editorial boards of Biomedical Engineering Online and the Journal of Biological Systems and has authored the definitive textbook "Advanced Methods and Tools for ECG Data Analysis," which is used by advanced students throughout the world in medical and engineering colleges and universities.

Branislav Vajdic, Ph.D.

Branislav is a founder of NewCardio and provides the strategic direction for the firm as its CEO. He is a proven creator of new technologies and has commercialized them into industry leading products. A 23 year veteran of Intel where he held various senior management positions including directing the Pentium & Flash memory development teams. He led a small team that designed Intel's first flash memory product and he holds several early Flash memory design patents. Branislav received a Ph.D. in electrical engineering from the University of Minnesota.

Professional Advisors

Morrison & Foerster LLP

Worldwide IP Attorney

Wilson Sonsini Goodrich & Rosati LLC

Corporate Attorney

Russell Bedford Stefanou Mirchandani LLP

Auditors